| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 117.93% | Barrington Research | $69 → $71 | Maintains | Outperform |
| 11/08/2023 | 35.05% | Needham | $50 → $44 | Maintains | Buy |
| 08/02/2023 | 53.47% | Needham | $36 → $50 | Reiterates | Buy → Buy |
| 06/21/2023 | 111.79% | Barrington Research | $60 → $69 | Maintains | Outperform |
| 06/20/2023 | 10.5% | Needham | → $36 | Reiterates | Buy → Buy |
| 06/13/2023 | 10.5% | Needham | → $36 | Upgrades | Hold → Buy |
| 02/13/2023 | — | Needham | Downgrades | Buy → Hold | |
| 02/07/2023 | 84.16% | Barrington Research | $61 → $60 | Maintains | Outperform |
| 02/07/2023 | 4.36% | Needham | $46 → $34 | Maintains | Buy |
| 01/20/2023 | 87.23% | Barrington Research | $70 → $61 | Maintains | Outperform |
| 04/28/2022 | 41.19% | Needham | $58 → $46 | Maintains | Buy |
| 02/04/2022 | 78.02% | Needham | $70 → $58 | Maintains | Buy |
| 11/10/2021 | 114.86% | Needham | $76 → $70 | Maintains | Buy |
| 09/08/2021 | 133.27% | Needham | $68 → $76 | Maintains | Buy |
| 07/23/2020 | 87.23% | Needham | → $61 | Upgrades | Hold → Buy |
| 12/11/2019 | — | Needham | Downgrades | Buy → Hold | |
| 11/01/2019 | — | Lake Street | Downgrades | Buy → Hold |
What is the target price for Surmodics (SRDX)?
The latest price target for Surmodics (NASDAQ: SRDX) was reported by Barrington Research on November 9, 2023. The analyst firm set a price target for $71.00 expecting SRDX to rise to within 12 months (a possible 117.93% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Surmodics (SRDX)?
The latest analyst rating for Surmodics (NASDAQ: SRDX) was provided by Barrington Research, and Surmodics maintained their outperform rating.
When is the next analyst rating going to be posted or updated for Surmodics (SRDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surmodics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surmodics was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Surmodics (SRDX) correct?
While ratings are subjective and will change, the latest Surmodics (SRDX) rating was a maintained with a price target of $69.00 to $71.00. The current price Surmodics (SRDX) is trading at is $32.58, which is out of the analyst's predicted range.
